[1]
Zimmermann, B., Starke, G., Shaw, D., Elger, B. and Koné, I. 2020. Actionability and scope should determine the extent of counselling for presymptomatic genetic testing. Swiss Medical Weekly. 150, 2728 (Jun. 2020), w20274. DOI:https://doi.org/10.4414/smw.2020.20274.